ZA885370B - Dna clone of human tissue factor inhibitor - Google Patents

Dna clone of human tissue factor inhibitor

Info

Publication number
ZA885370B
ZA885370B ZA885370A ZA885370A ZA885370B ZA 885370 B ZA885370 B ZA 885370B ZA 885370 A ZA885370 A ZA 885370A ZA 885370 A ZA885370 A ZA 885370A ZA 885370 B ZA885370 B ZA 885370B
Authority
ZA
South Africa
Prior art keywords
human tissue
tissue factor
dna clone
factor inhibitor
inhibitor
Prior art date
Application number
ZA885370A
Other languages
English (en)
Inventor
George John Broze Jr
John Broze George Jr
Kuniko Kusano Kretzmer
Kusano Kretzmer Kuniko
Tze-Chein Wun
Wun Tze-Chein
Original Assignee
Monsanto Co
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22137642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA885370(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monsanto Co, Univ Washington filed Critical Monsanto Co
Publication of ZA885370B publication Critical patent/ZA885370B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA885370A 1987-07-23 1988-07-22 Dna clone of human tissue factor inhibitor ZA885370B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7736687A 1987-07-23 1987-07-23

Publications (1)

Publication Number Publication Date
ZA885370B true ZA885370B (en) 1989-10-25

Family

ID=22137642

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA885370A ZA885370B (en) 1987-07-23 1988-07-22 Dna clone of human tissue factor inhibitor
ZA885371A ZA885371B (en) 1987-07-23 1988-07-22 Tissue factor inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA885371A ZA885371B (en) 1987-07-23 1988-07-22 Tissue factor inhibitor

Country Status (14)

Country Link
US (3) US6534276B1 (fr)
EP (1) EP0300988A3 (fr)
JP (1) JP2781391B2 (fr)
KR (1) KR900007261B1 (fr)
AU (1) AU604138B2 (fr)
BR (1) BR1100464A (fr)
CA (1) CA1338122C (fr)
DK (1) DK174522B1 (fr)
FI (1) FI97298C (fr)
IL (1) IL87172A (fr)
NO (1) NO174776C (fr)
NZ (1) NZ225534A (fr)
PT (1) PT88075B (fr)
ZA (2) ZA885370B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co ANDC of human tissue factor inhibitor
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
ATE135585T1 (de) * 1990-08-27 1996-04-15 Monsanto Co Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
KR100443572B1 (ko) * 2002-05-29 2004-08-09 광양청매실농원영농조합법인 매실 농축액 제조방법
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2298278B1 (fr) 2002-06-07 2015-11-11 Dyax Corp. Prévention et réduction de perte sanguine et la réponse inflammatoire
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
ES2663497T3 (es) 2005-12-29 2018-04-13 Dyax Corp. Inhibición de proteasas
WO2007092607A2 (fr) * 2006-02-09 2007-08-16 Genetech, Inc. Traitement d'infections virales hémorragiques au moyen d'un inhibiteur du facteur tissulaire
CA2696208A1 (fr) * 2007-08-21 2009-02-26 Genzyme Corporation Traitement par des inhibiteurs de la kallikreine
EP2227556B1 (fr) * 2007-11-19 2014-08-27 Celera Corporation Marqueurs de cancer du poumon et leurs utilisations
WO2010080833A1 (fr) 2009-01-06 2010-07-15 Dyax Corp. Traitement de la mucosite par des inhibiteurs de kallikréine
EP3459564B1 (fr) 2010-01-06 2021-10-27 Takeda Pharmaceutical Company Limited Protéines de liaison de kallicréine plasmatique
KR102169651B1 (ko) 2011-01-06 2020-10-23 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
IL247942B (en) 2014-03-27 2022-09-01 Dyax Corp Compositions and methods for drops in macular edema as a result of diabetes
IL311156A (en) 2015-12-11 2024-04-01 Takeda Pharmaceuticals Co Plasma kallikrein inhibitors and their uses in the treatment of hereditary angioedema attack

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) * 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
WO1988009817A1 (fr) * 1987-06-12 1988-12-15 Mount Sinai School Of Medicine Of The City Univers Clonage et expression du facteur de tissu humain
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor

Also Published As

Publication number Publication date
DK174522B1 (da) 2003-05-12
KR900007261B1 (en) 1990-10-06
NO174776B (no) 1994-03-28
NO174776C (no) 1994-07-06
US6534276B1 (en) 2003-03-18
DK413588A (da) 1989-01-24
US20030166194A1 (en) 2003-09-04
FI883477A0 (fi) 1988-07-22
US20040265981A1 (en) 2004-12-30
JPS6447799A (en) 1989-02-22
NZ225534A (en) 1991-02-26
US6806360B2 (en) 2004-10-19
DK413588D0 (da) 1988-07-22
FI97298C (fi) 1996-11-25
JP2781391B2 (ja) 1998-07-30
CA1338122C (fr) 1996-03-05
FI883477A (fi) 1989-01-24
AU1928688A (en) 1989-02-02
BR1100464A (pt) 2000-02-08
EP0300988A2 (fr) 1989-01-25
AU604138B2 (en) 1990-12-06
FI97298B (fi) 1996-08-15
IL87172A (en) 1994-12-29
PT88075A (pt) 1989-07-31
KR890001581A (ko) 1989-03-27
PT88075B (pt) 1995-06-30
NO883271L (no) 1989-01-24
EP0300988A3 (fr) 1990-04-11
NO883271D0 (no) 1988-07-22
US7060805B2 (en) 2006-06-13
IL87172A0 (en) 1988-12-30
ZA885371B (en) 1989-04-26

Similar Documents

Publication Publication Date Title
ZA885370B (en) Dna clone of human tissue factor inhibitor
GB2231265B (en) Therapeutic use of serotonin-antagonists
AP9000206A0 (en) Treatment of conditions & diseases
GB8709406D0 (en) Examining body of living tissues
GB8719343D0 (en) Medical treatment of fish
GB8707932D0 (en) Treatment of hair
GB2211865B (en) Treatment of carpets
GB2209526B (en) Dna clone of human type iv collagenase
GB8722529D0 (en) Treatment of burns
GB8700950D0 (en) Treatment of super-alloy surfaces
IL88310A0 (en) Treatment of factor viii inhibitors
GB8723765D0 (en) Treatment of water
GB9216360D0 (en) Treatment of blood
IE883282L (en) Treatment of bone diseases
GB8806116D0 (en) Treatment of skin diseases
ZA875652B (en) Therapeutic use of serotonin-antagonists
SG135193G (en) Therapeutic use of serotonin-antagonists
GB8901483D0 (en) Treatment of scar tissue
GB8708376D0 (en) Treatment of aids
SU1572502A1 (ru) Cпocoб oпpeдeлehия coctoяhия tkaheй пapoдohta
GB8611588D0 (en) Treatment of skin diseases
GB8829366D0 (en) Treatment of disease
ZA884990B (en) New use of 5-ht3-antagonists
GB8514096D0 (en) Treatment of skin diseases
IE860149L (en) Treatment of cardiovascular diseases